Cargando…
Methodological survey of missing outcome data in an alteplase for ischemic stroke meta‐analysis
OBJECTIVE: Recent national guidelines recommend alteplase treatment for ischemic stroke within 4.5 h of symptom‐onset based on meta‐analyses of randomized controlled clinical trials (RCT). A detailed description of missing outcome data (MOD) due to participant loss to follow‐up has never been publis...
Autor principal: | Garg, Ravi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541760/ https://www.ncbi.nlm.nih.gov/pubmed/35652287 http://dx.doi.org/10.1111/ane.13656 |
Ejemplares similares
-
Alteplase for Acute Ischemic Stroke Beyond 3 hours: Enthusiasm Outpaces Evidence
por: Garg, Ravi
Publicado: (2021) -
Effects of alteplase in the treatment of acute ischemic stroke
por: Yayan, Josef
Publicado: (2012) -
Cost-effectiveness of tenecteplase versus alteplase for acute ischemic stroke
por: Nguyen, Chi Phuong, et al.
Publicado: (2023) -
Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
por: Zhu, Annie, et al.
Publicado: (2022) -
Safety and efficacy of alteplase in the treatment of acute ischemic stroke
por: Micieli, Giuseppe, et al.
Publicado: (2009)